ArticleBMC neurology2026
Suicide attempt by a patient with an early phase of progressive supranuclear palsy: a case report.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuicidal ideation is reported in approximately 4% of patients with progressive supranuclear palsy (PSP); however, only three cases of PSP-related suicide attempts have been reported. Here, we report the case of a patient with early-stage PSP who attempted suicide using an organophosphorus agent. CASE PRESENTATION: An 81-year-old man with no medical history of severe depression impulsively attempted suicide by consuming an organophosphate. After improvement of the symptoms of organophosphate poisoning, the patient exhibited mild depressive mood, insomnia, mild amnesia, attention deficit, and frontal lobe dysfunction. In addition, he exhibited neck rigidity and postural instability, but no disturbance in ocular motility. Neuroradiological examination revealed findings characteristic of PSP, such as midbrain atrophy, third ventricle enlargement, and remarkably decreased dopamine transporter availability on single-photon emission computed tomography. Based on the clinical symptoms and neuroradiological findings, he was diagnosed with early-stage PSP.
conclusionsIn line with previous clinical reports and a forensic study regarding suicide and PSP, our case indicates that suicide may occur before the onset or in the early phases of PSP. Larger neuroradiological studies among older adults with signs of depression may be needed to clarify the involvement of PSP pathology in suicide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.